加利福尼亚州按疫苗接种状态划分的儿童多系统炎症综合征(MIS-C)病例
该研究通过加利福尼亚州被动疾病监测系统报告了5-17岁符合CDC病例定义的MIS-C儿童,比较未接种与接种辉瑞-BioNTech疫苗的12-17岁和5-11岁儿童的MIS-C发病率。结果显示,未接种儿童在12-17岁组(22.9,95%CI:10.5-49.8,p<0.0001)和5-11岁组(3.3,95%CI:1.6-6.7,p=0.0004)的MIS-C发病率均高于接种儿童,提示接种辉瑞-BioNTech疫苗对MIS-C具有保护作用。
要点
- 12-17岁组未接种儿童MIS-C发病率高于接种儿童,发病率比22.9(95%CI:10.5-49.8,p<0.0001)。
- 5-11岁组未接种儿童MIS-C发病率高于接种儿童,发病率比3.3(95%CI:1.6-6.7,p=0.0004)。
- 结果提示接种辉瑞-BioNTech疫苗对MIS-C具有保护作用。
核心结论
- 尽管MIS-C罕见,但结果提示接种辉瑞-BioNTech疫苗对MIS-C具有保护作用。
研究设计与样本
- 通过加利福尼亚州被动疾病监测系统报告5-17岁符合CDC病例定义的MIS-C儿童。
- 比较未接种与接种辉瑞-BioNTech疫苗的12-17岁和5-11岁儿童的MIS-C发病率。
主要发现
- 12-17岁组:未接种儿童66例新发(872,936人),接种儿童7例新发(2,117,575人)。
- 5-11岁组:未接种儿童51例新发(2,113,725人),接种儿童9例新发(1,221,293人)。
- 12-17岁组未接种较接种儿童的MIS-C发病率比为22.9(95%CI:10.5-49.8,p<0.0001)。
- 5-11岁组未接种较接种儿童的MIS-C发病率比为3.3(95%CI:1.6-6.7,p=0.0004)。
关键数值与推荐
- 12-17岁组发病率比22.9(95%CI:10.5-49.8,p<0.0001)。
- 5-11岁组发病率比3.3(95%CI:1.6-6.7,p=0.0004)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multisystem inflammatory syndrome in children (MIS-C) is a rare condition occurring after SARS-CoV-2 infection in children under 21 years of age. Children (5-17 years) with MIS-C meeting the Centers for Disease Control (CDC) case definition were reported via California's passive disease surveillance system. Incidence of MIS-C was compared in unvaccinated and Pfizer-BioNTech vaccinated children aged 12-17 and 5-11 years. In the 12-17 year-old age group, there were 66 new cases among 872,936 unvaccinated children and 7 new cases among 2,117,575 vaccinated children. In the 5-11 year-old age group, there were 51 new cases among 2,113,725 unvaccinated children and 9 new cases among 1,221,293 vaccinated children. Compared with vaccinated children, the incident rate ratio of MIS-C was higher among unvaccinated children in both the 12-17-year-old group (22.9, 95 % confidence interval [CI]: 10.5-49.8, p < 0.0001) and the 5-11-year-old group (3.3, 95 % CI: 1.6-6.7, p = 0.0004). While MIS-C is rare, our results suggest that vaccination with the Pfizer-BioNTech vaccine is protective against MIS-C.
引用
- Le Marchand C, Singson JRC, Clark A, et al. Multisystem inflammatory syndrome in children (MIS-C) cases by vaccination status in California. Vaccine. 2024. PMID: 39515133. doi:10.1016/j.vaccine.2024.126499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。